Raptiva Side Effects Attorney

Details: Parent Category: Lawsuit News Alerts; Category: Side Effects Lawsuit

Raptiva Side Effects Lawsuit Attorney

Raptiva, a drug that is no longer available in the U.S. because of its association with Progressive Multifocal Leukoencephalopathy (PML), is an injectable drug that is used to treat moderate and severe plaque psoriasis and who are candidates for systemic therapy or phototherapy in adults 18 years of age or older.

Progressive Multifocal Leukoencephalopathy is a serious and frequently fatal brain infection that is often acquired during childhood. It is caused by a polyomavirus that attacks the brain and the central nervous system. Most adult patients do not develop PMD but are infected with the JC virus. Patients who survive PML usually are permanently disabled.

PML symptoms include:

Problems with vision
memory loss
loss of coordination

Recommended dosage for Raptiva is a single conditioning dose of 0.7mg/kg followed by a weekly subcutaneous dose of 1mg/kg. The maximum

Raptiva

dose should not exceed a total of 200mg. Doses should be administered under the supervision of a physician unless it is deemed appropriate for self-injection with a medical follow-up after proper training in the preparation and injection is administered.

Raptiva should be inspected visually before administration for the presence of particulate matter and discoloration and should be administered using a disposable, sterile syringe and the needles that are provided. The product should not be used if discoloration or particulate matter is eminent.

Approved by the FDA in 2003, Raptiva actually blocks the establishment of certain immune cells referred to as T-cells and by blocking the passage of those cells into the skin. This, however, can increase the risk of dangerous infections in patients because it simply suppresses the body’s natural defense system.

Raptiva is supplied for subcutaneous injection in a one-use glass vial. It is a white to off-white, sterile, Iyophilized powder. Raptiva is designed to deliver 125mg of efalizumab in 1.25mL. The carton of Raptiva contains four trays of which contain one single-use vial that is intended to deliver 1215mg of efalizumab, a prefilled single-use diluents syringe consisting of 1.3mL of sterile water for injection, two alcohol prep pads, two25 gauge × 5/8 inch needles, and patient information insert along with a package insert.

The side effects lawsuit and adverse reactions associated with Raptiva are as follows:

transverse myelitis
bronchiolitis obliterans
aseptic meningitis
idiopathic hepatitis
sialadenitis
sensorineural hearing loss
Dyspnea
Asthma
Urticaria
Angioedema
maculopapular rash
dyspnea
asthma
urticaria
angioedema
maculopapular rash
Headache
Infection
Chills
Nausea
Pain
Myalgia
Flu Syndrome
Fever
Back pain
Acne
Side Effects Lawsuit Attorney
Raptiva Lawsuit
Raptiva Recall Lawyer

Free Case Review

Your Name:(*)

Please check your name for errors.
E-mail Address:(*)

Please provide your valid email address
Phone Number:

Invalid Input
Street Address:

Invalid Input
City:

Invalid Input
State, Select Your State From The List:

Invalid Input
Zip Code:(*)

Invalid Zip Code. Please enter your US Zip code.
Method you prefer we use to contact you?

Invalid Input
General Case Information Please briefly explain your situation:(*)

Please let us know your message.
By submitting this inquiry I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I also agree that the above does not constitute a request for legal advice and that I am not forming an attorney client relationship by submitting this question. I understand that I may only retain an attorney by entering into an agreement, and that I am not hereby entering into an agreement by submitting my question.